Who is popular today?

Digital therapeutics company HealthBeacon said on Tuesday that it plans to raise €25 million in an initial public offering (IPO) before floating on Euronext Dublin’s junior market.
The Irish company, which has developed a solution that helps patients better adhere to injectable medications schedules, signed a “transformational contract” this year with North American home appliances distributor Hamilton Beach Brands, providing it with a gateway to “millions of patients” in the US and Canada currently on injectable medication.
HealthBeacon, led by chief executive Jim Joyce and whose board includes former tánaiste Mary Harney, plans to use the proceeds from the IPO to build its team, invest in inventory and working capital to support product roll out, and further develop its platform in respect of technology development, research and development and develop a pipeline of future products.
The company said that certain existing shareholders may also sell down some of their holdings into the market subject to investor demand for the IPO shares.
Goodbody Stockbrokers is managing the IPO for the company.